Style | Citing Format |
---|---|
MLA | Navabi R, et al.. "Combined Therapy of Mesenchymal Stem Cells With a Glp-1 Receptor Agonist, Liraglutide, on an Inflammatory-Mediated Diabetic Non-Human Primate Model." Life Sciences, vol. 276, no. , 2021, pp. -. |
APA | Navabi R, Negahdari B, Hajizadehsaffar E, Hajinasrollah M, Jenab Y, Rabbani S, Pakzad M, Hassani SN, Hezavehei M, Jafariatrabi M, Tahamtani Y, Baharvand H (2021). Combined Therapy of Mesenchymal Stem Cells With a Glp-1 Receptor Agonist, Liraglutide, on an Inflammatory-Mediated Diabetic Non-Human Primate Model. Life Sciences, 276(), -. |
Chicago | Navabi R, Negahdari B, Hajizadehsaffar E, Hajinasrollah M, Jenab Y, Rabbani S, Pakzad M, et al.. "Combined Therapy of Mesenchymal Stem Cells With a Glp-1 Receptor Agonist, Liraglutide, on an Inflammatory-Mediated Diabetic Non-Human Primate Model." Life Sciences 276, no. (2021): -. |
Harvard | Navabi R et al. (2021) 'Combined Therapy of Mesenchymal Stem Cells With a Glp-1 Receptor Agonist, Liraglutide, on an Inflammatory-Mediated Diabetic Non-Human Primate Model', Life Sciences, 276(), pp. -. |
Vancouver | Navabi R, Negahdari B, Hajizadehsaffar E, Hajinasrollah M, Jenab Y, Rabbani S, et al.. Combined Therapy of Mesenchymal Stem Cells With a Glp-1 Receptor Agonist, Liraglutide, on an Inflammatory-Mediated Diabetic Non-Human Primate Model. Life Sciences. 2021;276():-. |
BibTex | @article{ author = {Navabi R and Negahdari B and Hajizadehsaffar E and Hajinasrollah M and Jenab Y and Rabbani S and Pakzad M and Hassani SN and Hezavehei M and Jafariatrabi M and Tahamtani Y and Baharvand H}, title = {Combined Therapy of Mesenchymal Stem Cells With a Glp-1 Receptor Agonist, Liraglutide, on an Inflammatory-Mediated Diabetic Non-Human Primate Model}, journal = {Life Sciences}, volume = {276}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Navabi R AU - Negahdari B AU - Hajizadehsaffar E AU - Hajinasrollah M AU - Jenab Y AU - Rabbani S AU - Pakzad M AU - Hassani SN AU - Hezavehei M AU - Jafariatrabi M AU - Tahamtani Y AU - Baharvand H TI - Combined Therapy of Mesenchymal Stem Cells With a Glp-1 Receptor Agonist, Liraglutide, on an Inflammatory-Mediated Diabetic Non-Human Primate Model JO - Life Sciences VL - 276 IS - SP - EP - PY - 2021 ER - |